Introduction: The study aims to present 1) a case report of an 18-year-old female patient with borderline personality disorder (BPD) 2) the diagnostic and treatment difficulties in BPD patients.
Materials and methods: The review of the literature from the years 1953-2020 searched from PubMed, Google Scholar, and Web of Science databases.
Discussion: Patient, 18-years old, hospitalized five times for psychiatric care, presenting self-injurious behaviours, hurting herself within forearms. A patient attempted suicide eight times. She is living with her divorced parents. The patient’s father has a new partner with whom he has children. The patient used marijuana and she was experiencing psychotic symptoms under its influence. She smokes 10 cigarettes per day and drinks alcohol once a week since she was 16 years old. Psychiatric problems appeared when the patient started learning in high school.
1. Borderline personality disorder (BPD) is a serious psychiatric condition of a difficult diagnosis that should be differentiated with many other psychiatric disorders such as an atypical or subclinical course of psychosis, affective disorders, or dissocial personality.
2. A therapeutic process of a person with BPD is based on psychotherapy and personalized treatment strategies, whereas, pharmacological treatment plays only a supporting role during BPD treatment.
3. Grant BF, Chou SP, Goldstein RB, Huang B, Stinson FS, Saha TD, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry 2008; 69:533.
7. World Health Organization. International Classification of Diseases. 11th ed. World Health Organization; Geneva, Switzerland: 2018.
8. American Psychiatric Association. DSM-5. Diagnostic and Statistical Manual of Mental Disorders, 5th edn. Washington, DC, USA: American Psychiatric Association, 2013.
9. Gaebel W, Zielasek J, Reed G. Mental and Behavioural Disorders in the ICD-11: Concepts, Methodologies, and Current Status. Psychiatria Polska, 2017; 51(2):169–95.
10. Chesney E, Goodwin GM, Fazel S. Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry, 2014; 13(2):153–160.
11. Paris J. Suicidality in Borderline Personality Disorder. Medicina (Kaunas), 2019; 55(6):223.
12. Quenneville AF, Kalogeropoulou E, Küng AL, Hasler R, Nicastro R, Prada P, Perroud N (2019). Childhood maltreatment, anxiety disorders and outcome in Borderline Personality Disorder. Psychiatry Research, 2020; 284:112688.
13. Amad A, Ramoz N, Thomas P, Jardri R, Gorwood P. Genetics of borderline personality disorder: Systematic review and proposal of an integrative model. Neuroscience & Biobehavioral Reviews, 2014; 40, 6–19.
14. Martín-Blanco A, Ferrer M, Soler J, Arranz MJ, Vega D, Calvo N, et al. The role of hypothalamus-pituitary-adrenal genes and childhood trauma in borderline personality disorder. Eur. Arch. Psychiatry Clin, 2016; 266(4): 307-316.
15. Amad, A, Ramoz, N, Peyre, H, Thomas, P, & Gorwood, P. FKBP5 gene variants and borderline personality disorder. Journal of Affective Disorders, 2019; 248: 26-28.
16. Helle A, Watts AL, Trull TJ, Sher KJ. Alcohol Use Disorder and Antisocial and Borderline Personality Disorders. Alcohol Research: Current Reviews, 2019; 40(1).
17. Baj J, Teresiński G, Buszewicz G, Sitarz E, Forma A, Karakuła K, et al. Magnesium, Calcium, Potassium, Sodium, Phosphorus, Selenium, Zinc, and Chromium Levels in Alcohol Use Disorder: A Review. Journal of Clinical Medicine, 2020; 9(6): 1901.
18. Grochowski C, Blicharska E, Bogucki J, Proch J, Mierzwińska A, Baj J, et al. Increased Aluminum Content in Certain Brain Structures is Correlated with Higher Silicon Concentration in Alcoholic Use Disorder. Molecules, 2019; 24(9): 1721.
19. Grochowski C, Blicharska E, Baj J, Mierzwińska A, Brzozowska K, Forma A, et al. Serum iron, Magnesium, Copper, and Manganese Levels in Alcoholism: A Systematic Review. Molecules, 2019; 24(7): 1361.
20. Johnson, JG, Cohen, P, Brown, J, Smailes, EM, Bernstein, DP. Childhood maltreatment increases risk for personality disorders during early adulthood. Arch. Gen. Psychiatry, 1999; 56(7): 600-606.
21. Hengartner MP, Ajdacic-Gross V, Rodgers S, Müller M, Rössler W. Childhood adversity in association with personality disorder dimensions: new findings in an old debate. Eur. Psychiatry, 2013; 28: 476–482.
22. Zanarini MC, Williams AA, Lewis RE, Reich RB, Vera SC, Marino MF, et al. Reported pathological childhood experiences associated with the development of borderline personality disorder. Am. J. Psychiatry, 1997; 154: 1101–1106.
23. Afifi TO, Mather A, Boman J, Fleisher W, Enns MW, Macmillan H, et al. Childhood adversity and personality disorders: results from a nationally representative population-based study. J. Psychiatr. Res, 2011; 45: 814–822.
24. Johnson JG, Cohen P, Chen H, Kasen S, Brook JS. Parenting behaviors associated with risk for offspring personality disorder during adulthood. Arch. Gen. Psychiatry, 2006; 63: 579.
25. Sharp C, Vanwoerden S, Jouriles EN, Godfrey DA, Babcock J, McLaren V, et al. Exposure to interparental intimate partner violence and the development of borderline features in adolescents. Child Abuse Negl, 2020; 12;103: 104448.
26. Nenadić I, Voss A, Besteher B, Langbein K, Gaser C. Brain structure and symptom dimensions in borderline personality disorder. European Psychiatry, 2020; 63(1): E9.
27. Grottaroli M, Delvecchio G, Bressi C, Moltrasio C, Soares JC, Brambilla P. Microstructural white matter alterations in borderline personality disorder: A minireview. J Affect Disord, 2020; 1;264: 249-255.
28. Davies G, Hayward M, Evans S, Mason O. A systematic review of structural MRI investigations within borderline personality disorder: Identification of key psychological variables of interest going forward. Psychiatry Res, 2020; 13;286: 112864.
29. Cyranka K, Rutkowski K, Mielimąka M, Sobański J, Smiatek-Mazgaj B, Klasa K, et al. Changes in personality functioning as a result of group psychotherapy with elements of individual psychotherapy in persons with neurotic and personality disorders – MMPI-2. Psychiatria Polska, 2016; 50(1): 105–26.
30. Keefe JR, Kim TT, Derubeis RJ, Streiner DL, Links PS, Mcmain SF. Treatment selection in borderline personality disorder between dialectical behavior therapy and psychodynamic psychiatric management. Psychological Medicine, 2020; 24: 1-9.
31. Putrino N, Casari L, Mesurado B, Etchevers M. Psychotherapists’ emotional and physiological reactions toward patients with either borderline personality disorder or depression. Psychotherapy Research, 2019; 11: 1–8.
32. Chakhssi F, Zoet JM, Oostendorp JM, Noordzij ML, Sommers-Spijkerman M. Effect of Psychotherapy for Borderline Personality Disorder on Quality of Life: A Systematic Review and Meta-Analysis. Journal of Personality Disorders, 2019; 1-15.
33. Ng FY, Carter PE, Bourke ME, Grenyer BF. What Do Individuals With Borderline Personality Disorder Want From Treatment? A Study of Self-generated Treatment and Recovery Goals. Journal of Psychiatric Practice, 2019; 25(2): 148–55.
34. Bozzatello P, Rocca P, Rosa MLD, Bellino S. Current and emerging medications for borderline personality disorder: is pharmacotherapy alone enough? Expert Opinion on Pharmacotherapy, 2019; 21(1): 47–61.
35. Amminger GP, Chanen AM, Ohmann S, Klier CM, Mossaheb N, Bechdolf A, et al. Omega-3 Fatty Acid Supplementation in Adolescents with Borderline Personality Disorder and Ultra-High Risk Criteria for Psychosis: A Post Hoc Subgroup Analysis of a Double—Blind, Randomized Controlled Trial. The Canadian Journal of Psychiatry, 2013; 58(7): 402–8.
36. Helweg-Joergensen S, Schmidt T, Lichtenstein MB, Pedersen SS. Using a Mobile Diary App in the Treatment of Borderline Personality Disorder: Mixed Methods Feasibility Study. JMIR Formative Research, 2019; 3(3).
37. Jacob GA, Hauer A, Köhne S, Assmann N, Schaich A, Schweiger U, et al. A Schema Therapy–Based eHealth Program for Patients with Borderline Personality Disorder (priovi): Naturalistic Single-Arm Observational Study. JMIR Mental Health, 2018; 5(4).
38. Cichoń L, Janas-Kozik M, Siwiec A, Rybakowski J. Clinical picture and treatment of bipolar affective disorder in children and adolescents. Psychiatria Polska, 2020; 54(1): 35–50.
40. Zimmerman M, Morgan TA. The relationship between borderline personality disorder and bipolar disorder. Dialogues Clin Neuro-sci, 2013; 15:155–169.
41. Gorostowicz A, Siwek M. Trudności w diagnostyce choroby afektywnej dwubiegunowej. Psychiatr Psychol Klin, 2018; 18(1):61-73.
42. Bipolar disorder and its diagnosis. In: National Collaborating Centre for Mental Health (UK): Bipolar Disorder: The Management of Bipolar Disorder in Adults, Children and Adolescents, in Primary and Secondary Care. NICE Clinical Guidelines, No. 38. British Psychological Society, Leicester 2006.
43. Bassett D: Borderline personality disorder and bipolar affective disorder. Spectra or spectre? A review. Aust N Z J Psychiatry, 2012;46: 327–339.
44. Popiel A. Zaburzenia osobowości. Z pogranicza – wyzwanie terapeutyczne. Akademia „Psychiatrii”, 2011; 8(2):64-78.
45. Cerullo MA, Strakowski SM. The prevalence and significance of substance use disorders in bipolar type I and II disorder. Subst Abuse Treat Prev Policy, 2007; 1;2:29.
46. Masland SR, Cummings MH, Null KE, Woynowskie KM, Choi-Kain LW. Changes in post-traumatic stress disorder symptoms during residential treatment for borderline personality disorder: a longitudinal cross-lagged study. Borderline Personal Disord Emot Dysregul, 2019; 6;6:15.
47. Cloitre M, Garvert DW, Weiss B, Carlson EB, Bryant RA. Distinguishing PTSD, Complex PTSD, and Borderline Personality Disorder: A latent class analysis. Eur J Psychotraumatol, 2014; 15;5.
48. Pastuszak A. Emotion regulation in borderline personality disorder – actual research directions. Psychiatria Polska, 2012; 46(3): 401-408